The tumor-promoting effect of CANA at low concentrations observed in our study may hinder in vivo animal examinations as a next step for its application in cancer chemotherapy; however, this may be overcome by agents that inhibit the NAD+ salvage pathway, such as NAMPT inhibitors. Here, NAMPT is linked to neoplasm.